Search

Your search keyword '"Kelly, Kara"' showing total 900 results

Search Constraints

Start Over You searched for: Author "Kelly, Kara" Remove constraint Author: "Kelly, Kara"
900 results on '"Kelly, Kara"'

Search Results

55. Lymphomas

57. Additional file 4 of Symptom management care pathway adaptation process and specific adaptation decisions

58. Additional file 3 of Symptom management care pathway adaptation process and specific adaptation decisions

59. Additional file 1 of Symptom management care pathway adaptation process and specific adaptation decisions

60. Additional file 2 of Symptom management care pathway adaptation process and specific adaptation decisions

61. Additional file 5 of Symptom management care pathway adaptation process and specific adaptation decisions

63. International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

64. Abstract B096: Food insecurity and receipt of Supplemental Nutrition Assistance Program (SNAP) benefits among income-eligible US pediatric acute lymphoblastic leukemia patients enrolled on a multi-center clinical trial

65. Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults

66. Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

68. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

71. Contributors

75. Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium

76. T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma

77. P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL

80. Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health

81. Genetic loss of SH2B3 in acute lymphoblastic leukemia

82. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Childrenʼs Oncology Group (COG AHOD0031) comparative analysis

83. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031.

86. Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

87. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium

89. Feasibility of oncology clinical trial-embedded evaluation of social determinants of health

90. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)

91. Durable remission for four pediatric patients with high‐risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group

92. Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001

93. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group

95. Contributors

98. The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

99. Performance of Next Generation Sequencing for Minimal Residual Disease Detection for Pediatric Patients with Acute Lymphoblastic Leukemia: Results from the Prospective Clinical Trial DFCI 16-001

100. Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium

Catalog

Books, media, physical & digital resources